Aligos Clinical Study Site 21 — Columbus, Ohio

Aligos Clinical Study Site 21 is a clinical research site located in Columbus, Ohio, United States 43004.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Aligos Clinical Study Site 21 has participated in 1 clinical trials.

Therapeutic areas: NASH, MASH, Metabolic Dysfunction-Associated Steatohepatitis.

Sponsors: Aligos Therapeutics.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Aligos Clinical Study Site 21?

Aligos Clinical Study Site 21 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Aligos Clinical Study Site 21 conducted?

Aligos Clinical Study Site 21 has 1 clinical trials on record. Their work covers NASH, MASH, Metabolic Dysfunction-Associated Steatohepatitis.

Is Aligos Clinical Study Site 21 accredited by Crixeo Health?

Aligos Clinical Study Site 21 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Aligos Clinical Study Site 21?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.